Cargando…
Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
Ovarian cancer is the most lethal gynecological malignancy due to its late detection and high recurrence rate. Resistance to conventional platinum-based therapies and metastasis are attributed to a population of cells within tumors called cancer stem cells, which possess stem-like features and are a...
Autores principales: | Muñoz-Galván, Sandra, Carnero, Amancio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349391/ https://www.ncbi.nlm.nih.gov/pubmed/32512891 http://dx.doi.org/10.3390/cells9061402 |
Ejemplares similares
-
Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2021) -
Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020) -
Role of Mitochondria in Cancer Stem Cell Resistance
por: García-Heredia, José Manuel, et al.
Publicado: (2020) -
NAD(+) metabolism, stemness, the immune response, and cancer
por: Navas, Lola E., et al.
Publicado: (2021) -
Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
por: Palomeras, Sònia, et al.
Publicado: (2018)